{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:43:22Z","timestamp":1762523002649,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Traditional Medicine and Technology Program","award":["2024ZL688"],"award-info":[{"award-number":["2024ZL688"]}]},{"name":"Medical Scientific Research Foundation of Zhejiang Province","award":["2025KY1160","2024KY1386","2025KY1161"],"award-info":[{"award-number":["2025KY1160","2024KY1386","2025KY1161"]}]},{"name":"Medical Scientific Research Foundation of Hangzhou City","award":["A20230086"],"award-info":[{"award-number":["A20230086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01812-z","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:55:21Z","timestamp":1751630121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intralesional and perilesional radiomics strategy based on different machine learning for the prediction of international society of urological pathology grade group in prostate cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhiping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"issue":"3","key":"1812_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1812_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1200\/JOP.2015.010017","volume":"12","author":"RC Chen","year":"2016","unstructured":"Chen RC, Rumble RB, Jain S. Active surveillance for the management of localized prostate cancer (Cancer care Ontario guideline): American society of clinical oncology clinical practice guideline endorsement summary. J Oncol Pract. 2016;12(3):267\u20139.","journal-title":"J Oncol Pract"},{"issue":"2","key":"1812_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4103\/UA.UA_124_17","volume":"10","author":"MH Kamel","year":"2018","unstructured":"Kamel MH, Khalil MI, Alobuia WM, Su J, Davis R. Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3\u2009+\u20094 versus 4\u2009+\u20093 prostate cancer. Urol Ann. 2018;10(2):203\u20138.","journal-title":"Urol Ann"},{"issue":"10","key":"1812_CR4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, et al. MRI-Targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl J Med. 2020;382(10):917\u201328.","journal-title":"N Engl J Med"},{"issue":"9","key":"1812_CR5","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.3390\/curroncol31090383","volume":"31","author":"W Malewski","year":"2024","unstructured":"Malewski W, Milecki T, Tayara O, Poletajew S, Kryst P, Tokarczyk A, et al. Role of systematic biopsy in the era of targeted biopsy: a review. Curr Oncol. 2024;31(9):5171\u201394.","journal-title":"Curr Oncol"},{"issue":"4","key":"1812_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/03915603211019982","volume":"88","author":"AA Santoro","year":"2021","unstructured":"Santoro AA, Di Gianfrancesco L, Racioppi M, Pinto F, Palermo G, Sacco E, et al. Multiparametric magnetic resonance imaging of the prostate: lights and shadows. Urologia. 2021;88(4):280\u20136.","journal-title":"Urologia"},{"issue":"8","key":"1812_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5694\/mja2.51722","volume":"217","author":"IS Williams","year":"2022","unstructured":"Williams IS, McVey A, Perera S, O\u2019Brien JS, Kostos L, Chen K, et al. Modern paradigms for prostate cancer detection and management. Med J Aust. 2022;217(8):424\u201333.","journal-title":"Med J Aust"},{"issue":"17","key":"1812_CR8","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.3390\/cancers16172951","volume":"16","author":"A Antolin","year":"2022","unstructured":"Antolin A, Roson N, Mast R, Arce J, Almodovar R, Cortada R, et al. The role of radiomics in the prediction of clinically significant prostate cancer in the PI-RADS v2 and v2.1 era: a systematic review. Cancers. 2022;16(17):2951.","journal-title":"Cancers"},{"key":"1812_CR9","doi-asserted-by":"publisher","first-page":"175628722211090","DOI":"10.1177\/17562872221109020","volume":"14","author":"M Ferro","year":"2022","unstructured":"Ferro M, de Cobelli O, Musi G, Del Giudice F, Carrieri G, Busetto GM, et al. Radiomics in prostate cancer: an up-to-date review. Ther Adv Urol. 2022;14:17562872221109020.","journal-title":"Ther Adv Urol"},{"issue":"1","key":"1812_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13244-024-01776-8","volume":"15","author":"A Guerra","year":"2024","unstructured":"Guerra A, Wang H, Orton MR, Konidari M, Papanikolaou NK, Koh DM, et al. Prediction of extracapsular extension of prostate cancer by MRI radiomic signature: a systematic review. Insights Imaging. 2024;15(1):217.","journal-title":"Insights Imaging"},{"issue":"4","key":"1812_CR11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.4251\/wjgo.v16.i4.1256","volume":"16","author":"S Ren","year":"2024","unstructured":"Ren S, Qian LC, Cao YY, Daniels MJ, Song LN, Tian Y, et al. Computed tomography-based radiomics diagnostic approach for differential diagnosis between early- and late-stage pancreatic ductal adenocarcinoma. World J Gastrointest Oncol. 2024;16(4):1256\u201367.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"1812_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11596-022-2535-2","volume":"42","author":"S Ren","year":"2022","unstructured":"Ren S, Tang HJ, Zhao R, Duan SF, Chen R, Wang ZQ. Application of unenhanced computed tomography texture analysis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma. Curr Med Sci. 2022;42(1):217\u201325.","journal-title":"Curr Med Sci"},{"key":"1812_CR13","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3389\/fonc.2020.01618","volume":"10","author":"S Ren","year":"2020","unstructured":"Ren S, Zhao R, Cui W, Qiu W, Guo K, Cao Y, et al. Computed Tomography-Based radiomics signature for the preoperative differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma. Front Oncol. 2020;10:1618.","journal-title":"Front Oncol"},{"issue":"12","key":"1812_CR14","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1007\/s00261-020-02678-1","volume":"45","author":"Y Hou","year":"2020","unstructured":"Hou Y, Bao ML, Wu CJ, Zhang J, Zhang YD, Shi HB. A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions. Abdom Radiol. 2020;45(12):4223\u201334.","journal-title":"Abdom Radiol"},{"issue":"10","key":"1812_CR15","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s11547-022-01541-1","volume":"127","author":"Y Hou","year":"2022","unstructured":"Hou Y, Bao ML, Wu CJ, Zhang J, Zhang YD, Shi HB. Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with 18F-PSMA-1007 PET: comparison among different volume segmentation thresholds. Radiol Med. 2022;127(10):1170\u20138.","journal-title":"Radiol Med"},{"issue":"10","key":"1812_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3390\/diagnostics11101829","volume":"11","author":"F Midiri","year":"2021","unstructured":"Midiri F, Vernuccio F, Purpura P, Alongi P, Bartolotta TV. Multiparametric MRI and radiomics in prostate cancer: a review of the current literature. Diagnostics. 2021;11(10):1829.","journal-title":"Diagnostics"},{"issue":"6","key":"1812_CR17","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/jmri.27565","volume":"54","author":"C Han","year":"2021","unstructured":"Han C, Ma S, Liu X, Liu Y, Li C, Zhang Y, et al. Radiomics models based on apparent diffusion coefficient maps for the prediction of high-grade prostate cancer at radical prostatectomy: comparison with preoperative biopsy. J Magn Reson Imaging. 2021;54(6):1892\u2013901.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"1812_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12672-023-00752-w","volume":"14","author":"C Zhou","year":"2023","unstructured":"Zhou C, Zhang YF, Guo S, Wang D, Lv HX, Qiao XN, et al. Multiparametric MRI radiomics in prostate cancer for predicting Ki-67 expression and Gleason score: a multicenter retrospective study. Discov Oncol. 2023;14(1):133.","journal-title":"Discov Oncol"},{"issue":"17","key":"1812_CR19","doi-asserted-by":"publisher","first-page":"15469","DOI":"10.1007\/s00432-023-05329-2","volume":"149","author":"L Li","year":"2023","unstructured":"Li L, Zhou X, Cui W, Li Y, Liu T, Yuan G, et al. Combining radiomics and deep learning features of intra-tumoral and peri-tumoral regions for the classification of breast cancer lung metastasis and primary lung cancer with low-dose CT. J Cancer Res Clin Oncol. 2023;149(17):15469\u201378.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1812_CR20","first-page":"284185125131764","volume":"18","author":"Y Li","year":"2025","unstructured":"Li Y, Zhou X, Zhang X, Zhang M, Sun S, Gai X, et al. Bi-parametric MRI radiomic model for prostate cancer diagnosis: value of intralesional and perilesional radiomics. Acta Radiol. 2025;18:2841851251317646.","journal-title":"Acta Radiol"},{"issue":"1","key":"1812_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12880-024-01548-2","volume":"24","author":"W Zhao","year":"2024","unstructured":"Zhao W, Hou M, Wang J, Song D, Niu Y. Interpretable machine learning model for predicting clinically significant prostate cancer: integrating intratumoral and peritumoral radiomics with clinical and metabolic features. BMC Med Imaging. 2024;24(1):353.","journal-title":"BMC Med Imaging"},{"key":"1812_CR22","doi-asserted-by":"crossref","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40(2):244\u201352.","DOI":"10.1097\/PAS.0000000000000530"},{"issue":"1","key":"1812_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00345-024-04995-2","volume":"42","author":"J Huang","year":"2024","unstructured":"Huang J, He C, Xu P, Song B, Zhao H, Yin B, et al. Development and validation of a clinical-radiomics model for prediction of prostate cancer: a multicenter study. World J Urol. 2024;42(1):275.","journal-title":"World J Urol"},{"key":"1812_CR24","doi-asserted-by":"publisher","first-page":"109020","DOI":"10.1016\/j.ejrad.2020.109020","volume":"128","author":"W Zhang","year":"2020","unstructured":"Zhang W, Mao N, Wang Y, Xie H, Duan S, Zhang X, et al. A radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients. Eur J Radiol. 2020;128:109020.","journal-title":"Eur J Radiol"},{"issue":"3","key":"1812_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00345-023-04305-2","volume":"41","author":"G Chiacchio","year":"2023","unstructured":"Chiacchio G, Castellani D, Nedbal C, De Stefano V, Brocca C, Tramanzoli P, et al. Radiomics vs radiologist in prostate cancer. Results from a systematic review. World J Urol. 2023;41(3):709\u201324.","journal-title":"World J Urol"},{"issue":"Suppl 1","key":"1812_CR26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.acra.2023.06.011","volume":"30","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Liu YF, Shu X, Qiao XF, Ai GY, He XJ. Peritumoral radiomics strategy based on ensemble learning for the prediction of Gleason grade group of prostate cancer. Acad Radiol. 2023;30(Suppl 1):S1\u201313.","journal-title":"Acad Radiol"},{"issue":"8","key":"1812_CR27","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.3390\/cancers12082200","volume":"12","author":"A Algohary","year":"2020","unstructured":"Algohary A, Shiradkar R, Pahwa S, Purysko A, Verma S, Moses D, et al. Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric MRI accurately stratifies prostate cancer risk: a multi-site study. Cancers. 2020;12(8):2200.","journal-title":"Cancers"},{"issue":"5","key":"1812_CR28","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jmri.27692","volume":"54","author":"SJ Hectors","year":"2021","unstructured":"Hectors SJ, Chen C, Chen J, Wang J, Gordon S, Yu M, et al. Magnetic resonance imaging radiomics-based machine learning prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions. J Magn Reson Imaging. 2021;54(5):1466\u201373.","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"1812_CR29","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.21037\/qims-22-265","volume":"12","author":"E Gresser","year":"2022","unstructured":"Gresser E, Schachtner B, St\u00fcber AT, Solyanik O, Schreier A, Huber T, et al. Performance variability of radiomics machine learning models for the detection of clinically significant prostate cancer in heterogeneous MRI datasets. Quant Imaging Med Surg. 2022;12(11):4990\u20135003.","journal-title":"Quant Imaging Med Surg"},{"key":"1812_CR30","doi-asserted-by":"publisher","first-page":"911426","DOI":"10.3389\/fonc.2022.911426","volume":"12","author":"YF Liu","year":"2022","unstructured":"Liu YF, Shu X, Qiao XF, Ai GY, Liu L, Liao J, et al. Radiomics-based machine learning models for predicting P504s\/P63 immunohistochemical expression: a noninvasive diagnostic tool for prostate cancer. Front Oncol. 2022;12:911426.","journal-title":"Front Oncol"},{"key":"1812_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3389\/fonc.2019.00807","volume":"9","author":"V Bourbonne","year":"2019","unstructured":"Bourbonne V, Valli\u00e8res M, Lucia F, Doucet L, Visvikis D, Tissot V, et al. MRI-derived radiomics to guide post-operative management for high-risk prostate cancer. Front Oncol. 2019;9:807.","journal-title":"Front Oncol"},{"issue":"4","key":"1812_CR32","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/cancers12040814","volume":"12","author":"V Bourbonne","year":"2020","unstructured":"Bourbonne V, Fournier G, Valli\u00e8res M, Lucia F, Doucet L, Tissot V, et al. External validation of an MRI-derived radiomics model to predict biochemical recurrence after surgery for high-risk prostate cancer. Cancers. 2020;12(4):814.","journal-title":"Cancers"},{"issue":"6","key":"1812_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11547-018-0966-4","volume":"124","author":"H Abdollahi","year":"2019","unstructured":"Abdollahi H, Mofid B, Shiri I, Razzaghdoust A, Saadipoor A, Mahdavi A, et al. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer. Radiol Med. 2019;124(6):555\u201367.","journal-title":"Radiol Med"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01812-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:55:22Z","timestamp":1751630122000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01812-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01812-z","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Hangzhou Traditional Chinese Medicine Hospital (No. 2022KY042), and the requirement for written informed consent was waived due to the retrospective nature of the research. We confirmed that the study was carried out in accordance with relevant guidelines and regulations of Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}